Now showing items 1-4 of 4

    • Chemoradiotherapy in gallbladder cancer 

      Aretxabala, Xabier de; Roa, Iván; Berríos Flores, Marcela Paz; Hepp, Juan; Gallardo, Jorge; Córdova, Andrés; Roa, Juan Carlos; León, Jorge; Maluenda, Fernando (WILEY-LISS, DIV JOHN WILEY & SONS INC, 2006-06-15)
      Gallbladder cancer (GC) is considered a rare disease associated with a poor prognosis. Unfortunately, the low number of cases makes the performance of trials addressing the role of adjuvant, neoadjuvant, and/or palliative ...
    • Early gallbladder cancer: Is further treatment necessary? 

      Aretxabala, Xabier de; Roa, Ivan; Hepp, Juan; Maluenda, Fernando; Mordojovich, Gerardo; Leon, Jorge; Roa, Juan (2009)
      Background and Objectives: The goal of this study was to evaluate a series of patients with early gallbladder cancer, focusing on the selection of treatment and the role of Rokitansky Aschoff sinus infiltration. Methods: ...
    • Gallbladder cancer: An analysis of a series of 139 patients with invasion restricted to the subserosal layer 

      Aretxabala, Xabier de; Roa, Iván; Burgos, Luis; Losada, Héctor; Roa, Juan Carlos; Mora, Javier; Hepp, Juan; León, Jorge; Maluenda, F. (ELSEVIER, 2006-02)
      The goal was to study our experience in the management of a series of patients with a potentially curative subscrosal gallbladder cancer who were prospectively treated by the authors. Between April 1988 and July 2004, 139 ...
    • Trasplante hepático en Chile: Aspectos generales, indicaciones y contraindicaciones (Documento de consenso) 

      Hepp, Juan; Zapata, Rodrigo; Buckel González, Erwin; Martínez, Jorge; Uribe Maturana, Mario; Díaz Jeraldo, Juan; Ferrario, Mario; Sanhueza, Edgar; Pérez, Rosa María; Hunter, Bessie; Ríos, Gloria; Humeres, Roberto; Poniachik Teller, Jaime; Oksenberg Reisberg, Dan; Arrese, Marco (SOC MEDICA SANTIAGO, 2008-06)
      Liver transplantation is an excellent therapeutic option for terminal liver disease, During the last decades the results of liver transplantation have improved significantly with a patient survival rate of nearly 90% at ...